REQUEST A DEMO
Total
USD $0.00
Search more companies

Implatec S.A.S. (Colombia)

Main Activities: Pharmacies and Drug Stores
Secondary Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Implatec S.A.S. Profile Updated: July 01, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Implatec S.A.S. is a company based in Colombia, with its head office in Envigado. The enterprise currently operates in the Pharmacies and Drug Stores sector. It was incorporated on September 20, 2018. There are currently 5 (2024) people employed by Implatec S.A.S.. From the latest financial highlights, Implatec S.A.S. reported a net sales revenue increase of 2.39% in 2023. Its’ total assets recorded a growth of 22.14%. The net profit margin of Implatec S.A.S. increased by 2.91% in 2023.

Headquarters
Cr 43A # 27A Sur 86 Lc 121 y 122
Envigado; Antioquia;

Contact Details: Purchase the Implatec S.A.S. report to view the information.

Website: http://implatec.com

Basic Information
Total Employees:
Purchase the Implatec S.A.S. report to view the information.
Outstanding Shares:
Purchase the Implatec S.A.S. report to view the information.
Incorporation Date:
September 20, 2018
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Company Performance
Financial values in the chart are available after Implatec S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
2.39%
Total operating revenue
2.39%
Net Profit (Loss) for the Period
113.91%
Total assets
22.14%
Total equity
33.32%
Net Profit Margin
2.91%
Return on Equity (ROE)
9.42%
Quick Ratio
-30.8%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?